Five-year follow-up of hemoptysis with no malignancy suspected on chest computed tomography: recurrence, lung cancer and mortality

Figures & data

Figure 1. Inclusion process and excluded patients by exclusion criterium.

Table 1. Baseline characteristics in absolute numbers and percentages of patients with relevant data available, where not stated otherwise.

Mean age (SD) (n = 609)	56.7 (14.1)
Male (n = 609)	369 (60.6)
Smoking (n = 600)	460 (76.7)
Current (n = 600)	258 (43.0)
Previous (n = 600)	202 (33.7)
Pack years >30 (n = 577)	155 (26.9)
Anticoagulant treatment (n = 592)	162 (27.4)
Amount of hemoptysis (n = 394)
Mild	340 (86.3)
Moderate–severe	49 (12.4)
Massive	5 (1.3)
Episodes (n = 546)
1	108 (19.8)
2–5	191 (35.0)
>5	247 (45.2)
Current/prev. lung disease (n = 601)	153 (25.5)

Figure 2. Patients with somatic disease diagnoses applicable at referral (present) and no longer applicable at referral (previous), as percentage of patients with relevant data available (n).

Figure 3. Patients according to etiology established at initial diagnostic workup.

Table 2. Diagnoses during follow-up and median time to diagnosis.

Diagnosis within 5 years	Patients diagnosed (%)	Median time to diagnosis, months (IQR)
Cancer	9 (1.5)	26 (18–33)
COPD	6 (1)	38 (11–47)
Bronchiectasis	7 (1.1)	9 (5–54)
Asthma	5 (0.8)	22 (11–23)
Interstitial lung disease	5 (0.8)	18 (10–21)